E75.21
Fabry (-Anderson) disease
Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 10 never code together
E75code
Excludes1
- mucolipidosis, types I-III (E77.0-E77.1)E77.0-E77.1
- Refsum's disease (G60.1)G60.1
E70-E88block
E00-E89chapter
Excludes1
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes 1
E00-E89chapter
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 9
- Anderson-Fabry disease E75.21
- Angiokeratoma — see Neoplasm, skin, benign
- corporis diffusum E75.21
- Degeneration, degenerative
- Disease, diseased — see also Syndrome
- Sweeley-Klionsky E75.21
- Disorder (of) — see also Disease
- Fabry (-Anderson) disease E75.21
- Glomerulonephritis N05.9
- in (due to)
- Fabry (-Anderson) disease E75.21
- in (due to)
- Lipidosis E75.6
- glycolipid E75.21
- Sweeley-Klionsky disease E75.21
Alongside this code 8 same parent — E75.2
Medications 1
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
AHA Coding Clinic® Licence required
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.